Nanoparticulate transport of oximes over an in vitro blood-brain barrier model.
about
The interaction of carbon nanotubes with an in vitro blood-brain barrier model and mouse brain in vivoTracking of magnetite labeled nanoparticles in the rat brain using MRIStrategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases.Assessing the transport of receptor-mediated drug-delivery devices across cellular monolayersSulfur mustard induced oxidative stress and its alteration using asoxime (HI-6).Drug development for the management of organophosphorus poisoning.Mini review on blood-brain barrier penetration of pyridinium aldoximes.Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood-brain barrier model.Cholinesterase reactivators and bioscavengers for pre- and post-exposure treatments of organophosphorus poisoning.Translation of in vitro to in vivo pyridinium oxime potential in tabun poisoning.Impedance-based cell monitoring: barrier properties and beyond.Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB).Near-complete adaptation of the PRiMA knockout to the lack of central acetylcholinesterase.Evaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells.Rapid-releasing of HI-6 via brain-targeted mesoporous silica nanoparticles for nerve agent detoxification.
P2860
Q28392435-CB592FD8-76E2-407B-ABEB-34C60CC8657DQ28540929-901A93C9-B0E5-45BF-8CE1-1AE9636A63CCQ30768284-25BD5508-28FA-4B44-8C47-D7EF40C74DEBQ35010941-B29AE441-2234-4211-ACA9-26E8B6FEE78DQ35636332-BF3CD36F-8B02-42DD-B551-036EB4E0312AQ37623393-6AFADBDE-702E-4992-A9EC-B0DECE9BD0D1Q38152506-FA701F35-5F03-4D82-BA88-8F2367D9CDC5Q38257801-BEDBEA2D-174F-4B5F-8561-A163795A80D4Q38275050-99BB3A73-F984-4474-AED0-2DCBE9288042Q38647131-D028C708-A3A6-4221-852D-72A137847646Q39329265-5FD9AE8D-01F2-47EC-84EB-138FB905CEF9Q40123151-4E3CFA87-BF66-4FD4-9A51-E9D8606E89EAQ41915054-ADB4E82C-DEFA-4C74-94D3-A26F44BA1572Q43679314-A09D2433-738A-48BE-8E45-C6AB360328FCQ47977811-80920918-A09C-4789-86A9-4F5B420D5C66Q48760641-5A42AE66-3246-4B5E-B981-B0A5A53BFE41Q49051116-EB739A19-6433-4322-80B8-F37DFEC37CAF
P2860
Nanoparticulate transport of oximes over an in vitro blood-brain barrier model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Nanoparticulate transport of oximes over an in vitro blood-brain barrier model.
@ast
Nanoparticulate transport of oximes over an in vitro blood-brain barrier model.
@en
type
label
Nanoparticulate transport of oximes over an in vitro blood-brain barrier model.
@ast
Nanoparticulate transport of oximes over an in vitro blood-brain barrier model.
@en
prefLabel
Nanoparticulate transport of oximes over an in vitro blood-brain barrier model.
@ast
Nanoparticulate transport of oximes over an in vitro blood-brain barrier model.
@en
P2093
P2860
P50
P1433
P1476
Nanoparticulate transport of oximes over an in vitro blood-brain barrier model.
@en
P2093
Anja Zensi
Hagen von Briesen
Judith Bungert
Jörg Kreuter
Jürgen Kufleitner
Miriam Dadparvar
Sascha Wien
Sylvia Wagner
Tikva Vogel
P2860
P304
P356
10.1371/JOURNAL.PONE.0014213
P407
P577
2010-12-03T00:00:00Z